Provided by Tiger Trade Technology Pte. Ltd.

ADiTx Therapeutics

0.8100
-0.0700-7.95%
Post-market: 0.82210.0121+1.49%19:59 EDT
Volume:123.72K
Turnover:105.26K
Market Cap:419.50K
PE:0.00
High:0.9031
Open:0.9000
Low:0.8008
Close:0.8800
52wk High:5,324.92
52wk Low:0.8008
Shares:517.90K
Float Shares:219.56K
Volume Ratio:1.06
T/O Rate:56.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-19,410.2600
EPS(LYR):-24,499.3531
ROE:-282.21%
ROA:-61.70%
PB:-0.05
PE(LYR):0.00

Loading ...

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:50 AM

Reuters
·
Nov 28, 2025

Top Premarket Gainers

MT Newswires Live
·
Nov 28, 2025

Chief M&A Officer Corinne Pankovcin Reports Sale of ADiTx Inc. Common Shares

Reuters
·
Nov 27, 2025

BRIEF-Aditxt Provides Updates On Its Growth Vision For Bitxbio™, Planned Digital Asset Treasury, Pearsanta’S Planned IPO, And Evofem’S Plan To Regain A National Listing

Reuters
·
Nov 18, 2025

Aditxt Inc. Seeks Shareholder Approval for Name Change to bitXbio, Employee Stock Purchase Plan in Upcoming Proxy Vote

Reuters
·
Nov 18, 2025

Aditxt Provides Updates on Its Growth Vision for Bitxbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, and Evofem’s Plan to Regain a National Listing

THOMSON REUTERS
·
Nov 18, 2025

ADiTx Inc. Delays Filing of Quarterly Report

Reuters
·
Nov 17, 2025

ADiTx Inc. Announces Date for Upcoming Special Meeting of Stockholders

Reuters
·
Nov 15, 2025

ADiTx Therapeutics trading halted, news pending

TIPRANKS
·
Nov 01, 2025

ADiTx Enacts 1-for-113 Reverse Stock Split

Reuters
·
Oct 30, 2025

Aditxt, Inc. (Nasdaq: Adtx) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025

THOMSON REUTERS
·
Oct 30, 2025

Aditxt Says Pearsanta Unit Begins Enrollment in Study of Test to Detect Endometriosis

MT Newswires Live
·
Oct 27, 2025

Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market

THOMSON REUTERS
·
Oct 27, 2025

Evofem Biosciences Inc: Delivered Notice of Termination to Aditxt Notifying That Co Was Exercising Its Right to Terminate Merger Agreement

THOMSON REUTERS
·
Oct 21, 2025

Press Release: Evofem Announces Voting Results from Special Meeting of Stockholders

Dow Jones
·
Oct 21, 2025

ADiTx Inc. Files Initial Statement of Beneficial Ownership for Christopher Jon Porcelli, General Counsel, CPO & CS

Reuters
·
Oct 03, 2025

ADiTx Inc. Files Initial Statement of Beneficial Ownership for Director Sylvia Hermina

Reuters
·
Sep 30, 2025